Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
When the list price of a drug is announced, insurance companies and Pharmacy Benefit Managers (PBMs) step in to negotiate with the drug manufacturers
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormonal pathways involved in appetite regulation and blood sugar control
Received: Accepted: Published: Issue date: DOI:
Comparison of the cardiovascular outcomes of GLP-1RAs and SGLT2 inhibitors may help the clinician to select the best personalised treatment approach for patients with type 2 diabetes [38]
The extension of the Bridge Model will enable eligible Part D beneficiaries across the country to access covered GLP-1 medications through December 2027, regardless of their Part D plan sponsors participation decisions
3 WADA Scientific ResearchInvestigation of TB-500 metabolism, synthesis of its metabolites, and detection limits
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
